Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $57.5 million.

  • Rockwell Medical's Liabilities and Shareholders Equity rose 70.42% to $57.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.3 million, marking a year-over-year increase of 482.24%. This contributed to the annual value of $59.2 million for FY2024, which is 1348.4% up from last year.
  • Latest data reveals that Rockwell Medical reported Liabilities and Shareholders Equity of $57.5 million as of Q3 2025, which was up 70.42% from $52.6 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Liabilities and Shareholders Equity peaked at $69.4 million during Q1 2021, and registered a low of $37.4 million during Q1 2022.
  • For the 5-year period, Rockwell Medical's Liabilities and Shareholders Equity averaged around $52.9 million, with its median value being $53.0 million (2024).
  • As far as peak fluctuations go, Rockwell Medical's Liabilities and Shareholders Equity plummeted by 4609.57% in 2022, and later surged by 3941.16% in 2024.
  • Over the past 5 years, Rockwell Medical's Liabilities and Shareholders Equity (Quarter) stood at $48.6 million in 2021, then decreased by 3.99% to $46.6 million in 2022, then grew by 11.88% to $52.2 million in 2023, then rose by 13.48% to $59.2 million in 2024, then dropped by 2.91% to $57.5 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $57.5 million for Q3 2025, versus $52.6 million for Q2 2025 and $54.0 million for Q1 2025.